Study on aromatase reaction mechanism using the inhibitors as probes
以抑制剂为探针的芳香酶反应机理研究
基本信息
- 批准号:15590066
- 负责人:
- 金额:$ 1.98万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In order to gain insight into the aromatase reaction mechanisms, we explored aromatase reactions of the powerful aromatase inhibitors 3-deoxyandrogens, 3-deoxyandrostenedione (1)and 3-deoxydehydroepiandrosterone (2), in relation to the stereomechanisms of the 19-oxygenation and the C(10)-C(19)bond cleavage reaction.1.Treatment of the 19-oxo derivatives of compounds 1 and 2, steroids 5 and 6, with NaB^2H_4 or NaB^3H_4 produced the corresponding [19,19^<-2>H_2] 19-ols 3 and 4 or [19R^<-3>H]-ols 3 and 4 as well as their [19S^<-3>H] isomers.2.Incubation of [19, 19^<-2>H_4] 3 and 4 with human placental microsomes in the presence of NADPH produced the 19-oxo metabolites 5 and 6, respectively, where the deuterium isotope effect was not observed in each case.3.[19R^<-3>H]- and [19S^<-3>H] 3 and 4 were also incubated with the microsomes described above, and ^3H_2O and ^3HCOOH released into the incubation mixtures were analyzed. The results indicate that a 19-pro-R hydrogen in stereospecifically eliminated in the conversion of Steroid 4 into the 19-oxo steroid 6 whereas a selectivity of 75 : 25 for pro-R : pro-S is observed in the case of steroid 3. In both cases, the C(10)-C(19) bond cleavage reaction, yielding ^3HCOOH, was established.4.Structure-activity relationships of 4-substituted derivatives of inhibitor 1,2α-substituted ADs as well as 2, 4, or 6-substituted estrogens as aromatase inhibitors were also studied in relation to elucidate the spatial nature of the active site of aromatase.
为了深入了解芳香酶反应的机理,我们探索了强大的芳香酶抑制剂3-脱氧雄烯二酮(1)和3-脱氧雄烯二酮(2)与19-加氧和C(10)-C(19)键裂解反应的立体机理。1.化合物1和2的19-氧代衍生物5和6与NaB^2H_4或NaB^3H_4处理得到相应的[19,19^<;-2>;H_2]19-醇3和4或[19R^<;-3>;2.在NADPH存在下,[19,19^<;-2>;H_4]3和4与人胎盘微生物体孵育,分别产生19-氧代谢物5和6,其中没有在每种情况下观察到氢同位素效应。H]3和4也与上述微粒体孵育,并分析了孵育混合物中释放出的^3H2O和^3HCOOH。结果表明,在甾体4转化为19-氧代甾体6的过程中,19-PRO-R氢被立体特异性地消除,而在甾体3中,PRO-R:PRO-S的选择性为75:25。在这两种情况下,都建立了C(10)-C(19)键断裂反应,生成^3HCOOH。4.还研究了4-取代的1,2-α取代的ADS以及2,4或6-取代的雌激素作为芳香酶抑制剂的构效关系。
项目成果
期刊论文数量(60)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Aromatase Reaction of 3-Deoxy Androgens : Steric Mode of the C-19 Oxygenation and Clevage of the C_<10>-C_<19> Bond by Human Placental Aromatase.
3-脱氧雄激素的芳香酶反应:人胎盘芳香酶对 C_10-C_19 键的 C-19 氧化和裂解的空间模式。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Mitsuteru Numazawa;et al.
- 通讯作者:et al.
Analysis of Reversible Inhibition of 16α-Hydroxyandrostenedione Aromatization in Human Placental Microsomes by Suicide Substrates of Androstenedione Aromatization.
雄烯二酮芳香化自杀底物对人胎盘微粒体中 16α-羟基雄烯二酮芳香化的可逆抑制分析。
- DOI:
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Mitsuteru Numazawa;et al.
- 通讯作者:et al.
沼沢 光輝: "Probing the active site of aromatase with 2-methyl-substituted androstenedione analogs"Steroids. 68. 503-513 (2003)
Mitsuteru Numazawa:“用 2-甲基取代的雄烯二酮类似物探测芳香酶的活性位点”Steroids 68. 503-513 (2003)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Gas Chromatography-Mass Spectrometric Analysis of Oxidative Reactions of [19,19^<-2>H_2] 19-Hydroxy-3-deoxy Androgens by Placental Aromatase. Absence of a Deuterium-Isotope Effect.
胎盘芳香酶对[19,19^-2H_2]19-羟基-3-脱氧雄激素氧化反应的气相色谱-质谱分析。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Mitsuteru Numazawa;et al.
- 通讯作者:et al.
Synthesis and Biochemical Properties of 6-Bromoandrostenedione Derivatives with a 2,2-Dimethyl or 2-Methyl Group as Aromatase Inhibitors.
具有 2,2-二甲基或 2-甲基基团的 6-溴雄烯二酮衍生物作为芳香酶抑制剂的合成和生化性质。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Mitsuteru Numazawa;et al.;沼沢 光輝;沼沢 光輝;沼沢 光輝;沼沢 光輝;沼沢 光輝;沼沢 光輝;沼沢 光輝
- 通讯作者:沼沢 光輝
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NUMAZAWA Mitsuteru其他文献
NUMAZAWA Mitsuteru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NUMAZAWA Mitsuteru', 18)}}的其他基金
Development of Anti-Breast Cancer Agents Having Diverse Functions
具有多种功能的抗乳腺癌药物的开发
- 批准号:
12672156 - 财政年份:2000
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Aromatase Reaction of Suicide Substrates of Aromatase and Their Inactivation Mechanisms.
芳香酶自杀底物的芳香酶反应及其失活机制。
- 批准号:
09672246 - 财政年份:1997
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ACTIVATION MECHANISM OF SUICIDE SUBSTRATE OF AROMATASE
芳香酶自杀底物的激活机制
- 批准号:
03671061 - 财政年份:1991
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Mechanistic Study of Estriol Biosynthesis and Its Inhibitor
雌三醇生物合成及其抑制剂的机理研究
- 批准号:
63571056 - 财政年份:1988
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
丹参酮ⅡA联合miR-29b inhibitor调控TGF-β1 / Smad3协同促进肌腱功能修复的机制研究
- 批准号:81702135
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
石斑鱼凋亡抑制因子Bax inhibitor 1(BI-1)在虹彩病毒SGIV侵染中的功能研究
- 批准号:31402335
- 批准年份:2014
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
马铃薯invertase inhibitor基因克隆及抗低温糖化品质改良
- 批准号:30270842
- 批准年份:2002
- 资助金额:20.0 万元
- 项目类别:面上项目
C1-Inhibitor在真核细胞中表达的研究
- 批准号:39270620
- 批准年份:1992
- 资助金额:4.0 万元
- 项目类别:面上项目
相似海外基金
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
EZH2 抑制剂、他泽美司他和 PD-1 阻断治疗晚期非小细胞肺癌的安全性和有效性的 Ib/II 期研究
- 批准号:
10481965 - 财政年份:2024
- 资助金额:
$ 1.98万 - 项目类别:
敗血症におけるplasminogen activator inhibitor-1阻害の効果検証
验证纤溶酶原激活剂抑制剂-1 抑制在脓毒症中的有效性
- 批准号:
24K02544 - 财政年份:2024
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
CCA's lineage heterogeneity and subsequent adaptive reprogramming upon acquired resistant to CDK4/6 inhibitor.
CCA 的谱系异质性以及随后获得对 CDK4/6 抑制剂耐药性后的适应性重编程。
- 批准号:
24K18491 - 财政年份:2024
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
FMO/ML-Guided Drug Design: Accelerating Novel Inhibitor Development and Drug Discovery
FMO/ML 引导的药物设计:加速新型抑制剂的开发和药物发现
- 批准号:
24K20888 - 财政年份:2024
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of a Cathepsin V inhibitor for application as an anti-tumour agent.
开发用作抗肿瘤剂的组织蛋白酶 V 抑制剂。
- 批准号:
MR/Y503447/1 - 财政年份:2024
- 资助金额:
$ 1.98万 - 项目类别:
Research Grant
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 1.98万 - 项目类别:
Continuing Grant
大腿骨頭壊死に対するSclerostin inhibitorによる骨再生の検討
使用 Sclerostin 抑制剂检查股骨头坏死骨再生
- 批准号:
24K12348 - 财政年份:2024
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Indication selection, patient stratification, and IND preparation for STX-002: the first-in-class LRG1 inhibitor for treatment of chronic kidney disease and immunotherapy-resistant tumours.
STX-002的适应症选择、患者分层和IND准备:用于治疗慢性肾病和免疫治疗耐药肿瘤的一流LRG1抑制剂。
- 批准号:
10092585 - 财政年份:2024
- 资助金额:
$ 1.98万 - 项目类别:
Collaborative R&D
Bilirubin Catabolism induces Plasminogen-Activator Inhibitor 1 (PAI-1) worsening Metabolic Dysfunction
胆红素分解代谢诱导纤溶酶原激活剂抑制剂 1 (PAI-1) 恶化代谢功能障碍
- 批准号:
10750132 - 财政年份:2024
- 资助金额:
$ 1.98万 - 项目类别:
Identification of novel therapeutic target and mechanism for PARP inhibitor combination therapy
PARP抑制剂联合治疗的新治疗靶点和机制的鉴定
- 批准号:
23K08100 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




